Using a loss-of-function approach, we confirmed the positive impact of FOSL2 on lincNORS expression in breast cancer cells (Supplementary Fig. 5c), predominantly at a lower oxygen concentration. The gene discussed is FOSL2; the disease is breast carcinoma.